FRS2 and urinary bladder carcinoma: Our previous whole-genome sequencing study further demonstrated that FRS2 copy number can increase by 3- to 25-fold in bladder cancer tissues, and this amplification correlates with elevated microvessel density and adverse prognosis [19].